Trending News Today: Congress May Permit Insurers to Charge Older People Higher Premiums

A new study questions whether opioids are the most effective remedy for the treatment of chronic pain, according to Kaiser Health News. A study published in the Journal of the American Medical Association evaluated 240 veterans with chronic back pain, osteoarthritis of the knee or hip with persistent and intense pain, according to KHN. The patients were either treated with opioids or non-opioid medications, including OTC drugs such as acetaminophen or naproxen, or prescription medications such as lidocaine or meloxicam. Within 6 months, the non-opioid group reported slightly less severe pain than the opioid group. Within a year, the researchers found “no difference between the groups in terms of pain interference with activities. And over time, the non-opioid group had less pain intensity and the opioid group had more side effects,” KHN reported. The study authors hypothesized that opioid tolerance may be an underlying reason for the findings, according to KHN.
 
Lost in the headlines of the flu epidemic has been the impact the outbreak has had on the homeless population, according to KHN. Due to overcrowding in homeless shelters and poor hygiene, the flu continues to spread in some communities despite showing signs of slowing down overall nationwide, according to KHN. The ongoing epidemic is ongoing in 45 states and Washington, DC, and has left thousands hospitalized and caused the deaths of 114 children, KHN reported. “The gravity of the flu for people who are homeless is enormous. And I think we often underestimate that,” Eowyn Rieke, board member of the National Health Care for the Homeless Council, told KHN. Concerns persist that multiple factors associated with homelessness could cause the flu epidemic to worsen within this population. “You’ve got very vulnerable people, who’ve got underlying health problems, poor access to health care, poor environmental conditions, crowded together,” Dr. Margot Kushel, a professor of medicine at the Zuckerberg San Francisco General Hospital and Trauma Center, told KHN. “And then, you throw in a particularly nasty flu and then you really got a recipe for disaster.”
 
The White House is pushing congressional leaders to include conservative goals in any legislation that seeks to fix problems with the Affordable Care Act, according to The Wall Street Journal. A memo obtained by the Journal encourages lawmakers to allow insurers to charge older people with premiums up to 5 times higher than younger people. The Journal reports the Trump administration is also asking Congress to expand access to health savings accounts and increase the amount of money individuals are allowed to contribute to it, and to support a permanent congressional appropriation that grants subsidies to insurers that decrease deductibles and co-pays for low-income consumers in exchange for exclusions on abortion coverage. “Although congressional efforts to provide taxpayer money to prop up the exchanges is understandable, any such efforts must also provide relief to middle-class families harmed by the law and protect life,” the memo stated, as reported by the Journal. “In order to support such efforts, the administration believes these three policies to provide greater choice and control for middle-class families must be included.”
 
 
 
 
 



Stay up to date on the latest news in specialty pharmacy by getting Specialty Pharmacy Times in your mailbox or inbox for free!

Click here to sign up for free for the bi-monthly Specialty Pharmacy Times print journal delivered to your address.

Click here to sign up for our email newsletters delivered every Monday, Wednesday, and Friday, in addition to breaking news alerts.

Click here to follow us on Facebook. 

Click here to follow us on Twitter. 

Click here to join our LinkedIn group. 


Most Popular

Related Articles

A look at last week's top stories in the world of pharmacy.
Officials with the FDA have approved bevacizumab (Avastin, Genentech) in combination with carboplatin and paclitaxel for patients with epithelial ovarian, fallopian tube, or primary peritoneal cancer.
Specialty drugs with limited distribution networks require pharmacies to put together an extensive request for proposal to gain access.
Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Advertise
Careers
Contact Us
Terms & Conditions
Privacy
MJH Associates >
Pharmacy Times
OTCGuide
American Journal of Managed Care
Cure
MD Magazine
ONCLive
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2018
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.
 

$vacMongoViewPlus$